Back to results
US 2025/0144031 A1Published application
Composition for treating spinal muscular atrophy
AssigneeHoffmann-La Roche Inc.
InventorsReto MAURER, Serge OBERDORF, Stefanie PETER, Katharina SENGER
Life of this patent
Estimating the term…
Abstract
Disclosed herein are pharmaceutical compositions and dosage forms including risdiplam that are useful in the treatment of subjects having SMA. The present disclosure also provides methods for preparing these pharmaceutical compositions and dosage forms, and methods of treating subjects having SMA utilizing the pharmaceutical compositions and dosage forms provided herein.
Claims29
1-51. (canceled)
A pharmaceutical composition, comprising:
- (a) a compound of formula (I):
- (b) crospovidone;
- and
- (c) an acidifier selected from the group consisting of tartaric acid, citric acid, and malic acid;
- wherein the pharmaceutical composition is in the form of a tablet.
2 more elements
Dependencies are inferred from the claim text.